Venus Concept’s Ai.me Robotic Tech Cleared For Fractional Skin Resurfacing

Venus Concept Inc. has been granted a U.S. Food and Drug Administration 510(k) clearance to market its AI.ME next generation robotic technology for fractional skin resurfacing. This technology platform is the first of its kind and is intended to provide minimally-invasive treatments for high-demand procedures. CEO Rajiv De Silva believes that AI.ME is a versatile platform and will continue to be developed for use in various areas of medical aesthetics.